医学
腹部成形术
组织学
病理
胶原酶
皮下组织
更安全的
梭菌
组织重塑
微生物胶原酶
外科
瘢痕组织
活检
软组织
机制(生物学)
伤口愈合
作者
Sachin M. Shridharani,Shekhar M Shrestha,Simrin Arya Singh,MacKenzie L Kennedy,Christina Uong,Ashish C. Bhatia
摘要
BACKGROUND: Collagenase clostridium histolyticum-aaes (CCH-aaes) is FDA-approved for cellulite treatment but was withdrawn because of high bruising incidence. Histological effects of CCH-aaes in humans remain poorly characterized. OBJECTIVES: The aim of the study was to evaluate histopathologic changes in human subcutaneous tissue following CCH-aaes injection and compare injection techniques to identify strategies that reduce bruising. METHODS: In this single-center, Phase 2b, nonrandomized, open-label exploratory study, 8 women undergoing elective abdominoplasty received CCH-aaes injections using either a 3-aliquot or a 7-injection hexagonal grid technique. Dosing schedules varied across groups. Excised abdominal tissue was analyzed histologically and immunohistochemically. Pathologists were blinded to injection technique and timing. RESULTS: CCH-aaes induced targeted enzymatic subcision and remodeling of subcutaneous tissue, with collagen degradation, neocollagenesis, and fat-lobule reorganization. The 3-aliquot technique produced more localized, intense histologic changes and greater bruising, whereas the grid technique caused diffuse but milder tissue effects. Bruising correlated with subcutaneous vascular disruption rather than dermal injury. No serious adverse events occurred. AUX-I (clostridial collagenase I-1 of the 2 purified bacterial collagenases in CCH-aaes)-neutralizing antibodies developed in 5 of 8 subjects, with no impact on safety or efficacy. CONCLUSIONS: CCH-aaes induces localized subcutaneous remodeling without dermal disruption. The 3-aliquot technique elicits more robust histologic effects but increases bruising risk, whereas the grid method offers a more diffuse, potentially safer alternative. These findings clarify the tissue-level mechanism of CCH-aaes and may guide safer clinical use should the product return to market. LEVEL OF EVIDENCE: 2 (THERAPEUTIC): For image description, please refer to the figure legend and surrounding text.
科研通智能强力驱动
Strongly Powered by AbleSci AI